REGN
Regeneron Pharmaceuticals Inc
Price:  
547.75 
USD
Volume:  
847,046.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron Relative Valuation

-0.1%
Upside

As of 2025-07-09, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 547.42 USD. This relative valuation is based on P/E multiples. With the latest stock price at 547.75 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is -0.1%.

The range of the Relative Valuation is 510.90 - 568.17 USD.

Range Selected
Trailing P/E multiples 12.3x - 13.4x 13.1x
Forward P/E multiples 13.1x - 14.2x 13.7x
Fair Price 510.90 - 568.17 547.42
Upside -6.7% - 3.7% -0.1%
547.75 USD
Stock Price
547.42 USD
Fair Price

Regeneron Relative Valuation - Historical P/E Data

Date P/E
2025-07-08 13.14
2025-07-07 12.91
2025-07-03 13.14
2025-07-02 13.14
2025-07-01 12.84
2025-06-30 12.60
2025-06-27 12.50
2025-06-26 12.50
2025-06-25 12.49
2025-06-24 12.53
2025-06-23 12.28
2025-06-20 12.23
2025-06-18 12.32
2025-06-17 12.21
2025-06-16 12.54
2025-06-13 12.70
2025-06-12 12.52
2025-06-11 12.44
2025-06-10 12.56
2025-06-09 12.42
2025-06-06 11.84
2025-06-05 11.59
2025-06-04 11.64
2025-06-03 11.71
2025-06-02 11.78
2025-05-30 11.77
2025-05-29 14.53
2025-05-28 14.20
2025-05-27 14.48
2025-05-23 14.12
2025-05-22 14.32
2025-05-21 14.51
2025-05-20 14.75
2025-05-19 14.32
2025-05-16 14.26
2025-05-15 14.04
2025-05-14 13.71
2025-05-13 13.78
2025-05-12 13.81
2025-05-09 12.67
2025-05-08 13.14
2025-05-07 13.46
2025-05-06 13.40
2025-05-05 14.48
2025-05-02 14.53
2025-05-01 14.16
2025-04-30 14.37
2025-04-29 13.65
2025-04-28 14.66
2025-04-25 14.46